Article
CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.
International journal of cancer - 1 Sept 2017
Vedeld Hege Marie, Merok Marianne, Jeanmougin Marine, Danielsen Stine A, Honne Hilde, Presthus Gro Kummeneje, Svindland Aud, Sjo Ole H, Hektoen Merete, Eknaes Mette, Nesbakken Arild, Lothe Ragnhild A, Lind Guro E
Abstract excerpt
The prognostic value of CpG island methylator phenotype (CIMP) in colorectal cancer remains unsettled. We aimed to assess the prognostic value of this phenotype analyzing a total of 1126 tumor samples obtained from two Norwegian consecutive colorectal cancer series. CIMP status was determined by analyzing the 5-markers CAGNA1G, IGF2, NEUROG1, RUNX3 and SOCS1 by quantitative methylation specific PCR (qMSP). The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
